Nalbuphine for the Treatment of Opioid Induced Pruritus in Children

NCT00323154 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

134

Enrollment

OTHER

Sponsor class

Conditions

Pruritis

Interventions

DRUG: Nalbuphine

Sponsor

University of British Columbia